These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18946237)

  • 21. [Is the frequency of pre-seasonal manifestation in patients with Japanese cedar pollinosis so high?].
    Okuda M; Ohkubo K; Gotoh M; Ishida Y
    Arerugi; 2005 Jul; 54(7):636-40. PubMed ID: 16229363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Clin Exp Allergy; 2005 May; 35(5):664-71. PubMed ID: 15898991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
    Masuda K
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):185-7. PubMed ID: 16098609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Allergol Int; 2009 Jun; 58(2):237-45. PubMed ID: 19307778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Asian sand dust on Japanese cedar pollinosis.
    Ogi K; Takabayashi T; Sakashita M; Susuki D; Yamada T; Manabe Y; Fujieda S
    Auris Nasus Larynx; 2014 Dec; 41(6):518-22. PubMed ID: 24928063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
    Ito Y; Takahashi Y; Fujita T; Fukuyama S
    Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severity assessment of Japanese cedar pollinosis using the practical guideline for the management of allergic rhinitis in Japan and the allergic rhinitis and its impact on asthma guideline.
    Gotoh M; Yuta A; Okano M; Ohta N; Matsubara A; Okubo K
    Allergol Int; 2013 Jun; 62(2):181-9. PubMed ID: 23435559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Present situation of cedar pollinosis in Japan and its immune responses.
    Okamoto Y; Horiguchi S; Yamamoto H; Yonekura S; Hanazawa T
    Allergol Int; 2009 Jun; 58(2):155-62. PubMed ID: 19307773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new lipid transfer protein homolog identified as an IgE-binding antigen from Japanese cedar pollen.
    Ibrahim AR; Kawamoto S; Nishimura M; Pak S; Aki T; Diaz-Perales A; Salcedo G; Asturias JA; Hayashi T; Ono K
    Biosci Biotechnol Biochem; 2010; 74(3):504-9. PubMed ID: 20208354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis.
    Nagao M; Hiraguchi Y; Hosoki K; Tokuda R; Usui T; Masuda S; Yamaguchi M; Fujisawa T
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():47-53. PubMed ID: 18504407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study.
    Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
    Auris Nasus Larynx; 2016 Feb; 43(1):50-5. PubMed ID: 26197940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Japanese cedar pollinosis in infants in the allergy clinic].
    Masuda S; Terada A; Fujisawa T; Iguchi K
    Arerugi; 2000 Dec; 49(12):1138-45. PubMed ID: 11197879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a prospective, randomized, open-label study.
    Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
    Allergol Int; 2015 Apr; 64(2):161-8. PubMed ID: 25838092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of cross-reactivity between Japanese cedar (Cryptomeria japonica) pollen and tomato fruit extracts by RAST inhibition and immunoblot inhibition.
    Kondo Y; Tokuda R; Urisu A; Matsuda T
    Clin Exp Allergy; 2002 Apr; 32(4):590-4. PubMed ID: 11972607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Japanese cedar pollinosis in children in our allergy clinic].
    Masuda S; Takeuchi K; Yuta A; Okawa C; Ukai K; Sakakura Y
    Arerugi; 1998 Nov; 47(11):1182-9. PubMed ID: 9893335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
    Kawakami A; Koketsu R; Suzukawa M; Nagao M; Hiraguchi Y; Tokuda R; Fujisawa T; Nagase H; Ohta K; Yamamoto K; Yamaguchi M
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():54-60. PubMed ID: 18504408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A correlation between symptom severity and unbalanced reactive IgA production in Japanese cedar pollinosis patients.
    Komatsu N; Harada M; Nakagawa M; Tanaka Y; Ono T; Gohara S; Ohkubo K; Itoh K
    Asian Pac J Allergy Immunol; 2008; 26(2-3):97-104. PubMed ID: 19054927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific IgE to Japanese cypress (Chamaecyparis obtusa) in patients with nasal allergy.
    Ito H; Nishimura J; Suzuki M; Mamiya S; Sato K; Takagi I; Baba S
    Ann Allergy Asthma Immunol; 1995 Apr; 74(4):299-303. PubMed ID: 7719888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
    Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
    Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit.
    Enomoto T; Lu HQ; Yin M; Sakoda T; Dake Y; Enomoto K; Ide T; Cheng L
    J Investig Allergol Clin Immunol; 2009; 19(4):299-305. PubMed ID: 19639726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.